Home › NDC Lookup › Ingredients › Triamcinolone Acetonide › 41167-5800-01
Nasacort Allergy 24HR Triamcinolone Acetonide 55 ug Spray, Metered — NDC 41167-5800-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Nasacort Allergy 24HR Triamcinolone Acetonide 55 ug Spray, Metered — NDC 41167-5800-1 (Billing 41167-5800-01)

by Chattem, Inc. · 1 BOTTLE, SPRAY in 1 CARTON / 30 SPRAY, METERED in 1 BOTTLE, SPRAY

This is a package of Nasacort Allergy 24HR Triamcinolone Acetonide 55 ug Spray, Metered from Chattem, Inc., marketed since Feb 2014 and currently FDA-listed. It is the main listing for this product, which comes in 6 package sizes.

NDC 41167-5800-01
🏷️ FDA NDC (as labeled) 41167-5800-1 billing pads the package segment with a zero
This package
Contains30 spray, metered in 1 bottle, spray Pack sizes6 compare ↓
OTC Brand On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Triamcinolone Acetonide (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Sep 28, 2023 — Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial. (Eugia US LLC) · FDA recall D-0041-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 41167-5800-1
Product NDC 41167-5800
11-digit billing NDC 41167580001
NCPDP billing unit ML — per mL (volume)
RxCUI 1797913, 1797915
UNII F446C597KA
Application # NDA020468
SPL Set ID 4bff57a5-cce0-401c-a0fe-23c65c1b7ddc
Established class (EPC) Corticosteroid
Mechanism of action Corticosteroid Hormone Receptor Agonists
DEA schedule Non-controlled
Marketing category NDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2014-02-03
Route NASAL
Dosage form SPRAY, METERED
Substance TRIAMCINOLONE ACETONIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 42200060103210
GPI class Nasacort Allergy 24HR
GCN Seq No 072054
GCN 36145
HICL code 002891
Ingredient (HICL) Triamcinolone Acetonide
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q7
Therapeutic class — intermediate (HIC2) Nasal Preparations
HIC3 code Q7P
Therapeutic class — specific (HIC3) Nasal Anti-Inflammatory Steroids
AHFS code 48:10.08.00
AHFS class Corticosteroids (Respiratory Tract)
FDB label name NASACORT ALLERGY 24HR SPRAY
FDB brand name Nasacort
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 072054
  • GCN: 36145
  • GPI-14 (Medi-Span): 42200060103210
  • HICL (First Databank): 002891
  • AHFS class code: 48:10.08.00
  • RxCUI (RxNorm): 1797913
Why two NDCs? The FDA registers this code as 41167-5800-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 41167-5800-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Corticosteroid class.

Pharmacologic class Corticosteroid
Drug family (ATC) Corticosteroids for local oral treatment, Corticosteroids, Corticosteroids, moderately potent (group II)
How it works Corticosteroid Hormone Receptor Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name NASACORT ALLERGY 24HR SPRAY Ingredient Triamcinolone Acetonide
📖 What it is MedlinePlus · NLM

Triamcinolone nasal spray is used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caused by hay fever or other allergies. Triamcinolone nasal spray should not be used to treat symptoms (e.g., sneezing, stuffy, runny, or itchy nose) caused by the common cold. Triamcinolone is in a class of medications called corticosteroids. It works by blocking the release of certain natural substances that cause allergy symptoms.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves hay fever and other upper respiratory allergy symptoms. That means nasal congestion, runny nose, sneezing and itchy nose. It is not for the common cold.
  • Some symptoms may get better on the first day. It can take up to one week of daily use to feel the most relief. If you don't improve after a week, stop and talk to a doctor.
  • Shake the bottle well, then spray into your nostrils once a day while sniffing gently. Prime a new bottle first, and again if you haven't used it for more than 2 weeks. Follow the...
  • Children 2 and older can use it, with an adult supervising. It's not for children under 2. Growth may be slower in some children, so talk to your child's doctor if they need it for...
📖 Read our full Triamcinolone Nasal Spray guide →
8
Nutrient depletion considerations

Triamcinolone Acetonide may be associated with lower levels of 8 nutrients — worth a chat with your pharmacist, not a cause for alarm.

An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
41167-5800-01 You're viewing this Main listing 1 BOTTLE, SPRAY in 1 CARTON / 30 SPRAY, METERED in 1 BOTTLE, SPRAY 2017-09-07 — Active
41167-5800-02 41167-5800-2 2 BOTTLE, SPRAY in 1 CARTON / 120 SPRAY, METERED in 1 BOTTLE, SPRAY 2014-02-03 — Active
41167-5800-03 41167-5800-3 1 BOTTLE, SPRAY in 1 CARTON / 60 SPRAY, METERED in 1 BOTTLE, SPRAY 2014-02-03 — Active
41167-5800-05 41167-5800-5 1 BOTTLE, SPRAY in 1 CARTON / 120 SPRAY, METERED in 1 BOTTLE, SPRAY 2014-02-03 — Active
41167-5800-07 41167-5800-7 3 BOTTLE, SPRAY in 1 CARTON / 120 SPRAY, METERED in 1 BOTTLE, SPRAY 2014-02-03 — Discontinued by firm
41167-5800-06 41167-5800-6 4 BOTTLE, SPRAY in 1 CARTON / 120 SPRAY, METERED in 1 BOTTLE, SPRAY 2021-07-01 — Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 1 bottle, spray in 1 carton / 30 spray, metered in 1 bottle, spray.
What NDC number is used to bill for this package of Nasacort Allergy 24HR Triamcinolone Acetonide 55 ug Spray, Metered?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Sense Nasal Allergy 55 ug 00113-0443-01 L. 1 bottle $0.739 — Availability likely —
Nasal Allergy 55 ug 00536-1457-69 Rugby 1 bottle $0.739 — Availability likely —
Triamcinolone Acetonide Nasal 55 ug 45802-0109-01 Padagis 1 bottle $0.739 — Availability likely —
Good Neighbor Pharmacy 24 Hour Nasal Allergy 55 ug 46122-0385-76 Amerisource 1 bottle $0.739 — Availability likely —
Triamcinolone acetonide 55 ug 60505-6275-07 Apotex 1 bottle $0.739 — Availability likely —
Triamcinolone acetonide 55 ug 70000-0702-01 CARDINAL 1 bottle $0.739 — Discontinued —
Triamcinolone Acetonide 55 ug 70000-0742-01 CARDINAL 1 bottle $0.739 — Availability likely —
foster and thrive 24 hour nasal allergy 55 ug 70677-1023-01 Strategic 1 bottle $0.739 — Availability likely —
Allergy Nasal 55 ug 00363-0811-01 Walgreen 1 bottle — — FDA listed —
Up and Up Nasal Allergy 55 ug 11673-0717-01 Target 1 bottle — — FDA listed —
Nasal Allergy 55 ug 11822-0443-01 Rite 1 bottle — — Discontinued —
Signature Care Nasal Allergy 55 ug 21130-0443-01 Safeway 1 bottle — — FDA listed —
Nasal Allergy 55 ug 21130-0613-02 Safeway 1 bottle — — FDA listed —
Nasal Allergy Relief 55 ug 30142-0665-01 Kroger 1 bottle — — FDA listed —
nasal allergy 55 ug 30142-0813-01 Kroger 1 bottle — — FDA listed —
Topcare Nasal Allergy 55 ug 36800-0621-01 Topco 1 bottle — — FDA listed —
Nasal Allergy 55 ug 37808-0443-01 H 1 bottle — — FDA listed —
Equaline nasal allergy 55 ug 41163-0443-01 United 1 bottle — — FDA listed —
Nasacort Allergy 24HR 55 ugthis 41167-5800-01 Chattem, 1 bottle — — FDA listed —
24 Hour Nasal Allergy 55 ug 41250-0443-01 Meijer 1 bottle — — FDA listed —
CareOne Allergy Relief 55 ug 41520-0443-01 American 1 bottle — — Discontinued —
Equate Nasal Allergy 55 ug 49035-0443-01 Wal-Mart 1 bottle — — FDA listed —
Nasacort 55 ug 50090-1444-00 A-S 1 bottle — — FDA listed —
allergy relief 55 ug 51316-0711-01 CVS 1 bottle — — FDA listed —
DG Health Nasal Allergy 55 ug 55910-0280-02 Dolgencorp, 1 bottle — — FDA listed —
Nasal Allergy 55 ug 59779-0746-01 CVS 1 bottle — — FDA listed —
Triamcinolone acetonide 55 ug 69168-0482-01 Allegiant 1 bottle — — FDA listed —
Triamcinolone Acetonide Nasal 55 ug 72162-2289-02 Bryant 1 bottle — — FDA listed —
Basic Care Nasal Allergy 55 ug 72288-0443-01 Amazon.com 1 bottle — — FDA listed —
Nasal Allergy 55 ug 42507-0443-01 HyVee 1 bottle — — FDA listed —
Triamcinolone Acetonide 55 ug 58602-0035-07 Aurohealth 1 bottle — — FDA listed —
Childrens Triamcinolone Acetonide 55 ug 58602-0037-11 Aurohealth 1 bottle — — FDA listed —
About this product: this is the brand-name version. FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2014
On the market since
Feb 2014
📍
2026
Currently FDA-listed
12 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerChattem, Inc.
Application holderCHATTEM INC DBA SANOFI CONSUMER HEALTHCARE
FDA applicationNDA020468 (NDA)
Labeler code41167
First marketedFeb 2014
Product typeHuman Otc Drug
Portfolio157 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 20 words ▾

Uses temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal congestion runny nose sneezing itchy nose

⏱️ Dosage and Administration ~1 min read ▾

Directions Read insert (inside package) on how to: get a new bottle ready (primed) before first use prime bottle again if not used for more than 2 weeks use the spray clean the spray nozzle ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER adults and children 12 years of age and older once daily, spray 2 times into each nostril while sniffing gently once your allergy symptoms improve, reduce to 1 spray in each nostril per day CHILDREN 2 TO UNDER 12 YEARS OF AGE the growth rate of some children may be slower while using this product.

Talk to your child’s doctor if your child needs to use the spray for longer than two months a year. children 6 to under 12 years of age an adult should supervise use once daily, spray 1 time into each nostril while sniffing gently if allergy symptoms do not improve, increase to 2 sprays in each nostril per day. Once allergy symptoms improve, reduce to 1 spray in each nostril per day. children 2 to under 6 years of age an adult should supervise use once daily, spray 1 time into each nostril while sniffing gently children under 2 years of age do not use do not use more than directed if you forget a dose, do not double the next dose do not spray into eyes or mouth if allergy symptoms do not improve after one week, stop using and talk to a doctor do not use for the common cold shake well before each use

⚠️ Warnings 213 words ▾

Warnings Do not use in children under 2 years of age if you have ever had an allergic reaction to any of the ingredients Ask a doctor before use if you have had recent nose ulcers or nose surgery have had a nose injury that has not healed are using a steroid medicine for asthma, allergies or skin rash have an eye infection have or had glaucoma or cataracts When using this product the growth rate of some children may be slower some symptoms may get better on the first day of treatment. It may take up to one week of daily use to feel the most symptom relief. do not share this bottle with anyone else as this may spread germs remember to tell your doctor about all the medicines you take, including this one Stop use and ask a doctor if you have, or come into contact with someone who has, chickenpox, measles or tuberculosis you have or develop symptoms of an infection such as a persistent fever you have any change in vision you have severe or frequent nosebleeds If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 10 words ▾

Active ingredient (in each spray) Triamcinolone acetonide 55 mcg (glucocorticoid)

🧪 Inactive Ingredients 23 words ▾

Inactive ingredients benzalkonium chloride, carboxymethylcellulose sodium, dextrose, edetate disodium, hydrochloric acid or sodium hydroxide (for pH adjustment), microcrystalline cellulose, polysorbate 80, purified water

🎯 Purpose 4 words ▾

Purpose Allergy symptom reliever

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Triamcinolone Acetonide (matched by generic name) — the program that covers self-administered drugs. 22 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Triamcinolone Acetonide. CMS lists 5 products for this generic; we show the highest-spend one. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$17.79M
Claims incl. refills
1.7M
Beneficiaries
1.4M
Spend / beneficiary
$13.01
Spend / claim
$10.45
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Nasacort Allergy 24HR (this brand).

Top reported reactions

Pruritus2,557
Rash2,460
Pain2,091
Fatigue2,016
Nausea1,944
Headache1,776
Condition Aggravated1,717

Age at onset

Neonate11
Infant52
Child630
Adolescent477
Adult7,114
Elderly3,340

Reporter sex

28,023 reports

Serious outcomes

Hospitalization6,157
Death3,026
Life-threatening2,336
Disabling2,323
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 3,651 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Chattem, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 5 other package presentations of this same product, including 1 bottle (41167-5800-03), 1 bottle (41167-5800-05), 2 bottles (41167-5800-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Chattem, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.